Metsera Inc (MTSR) Short-Term Debt to Capital

Metsera Inc - graphic logo of issuer MTSR

The price action history of Metsera Inc (MTSR) demonstrates metrics at the level of 0.01. This startup focuses on combating obesity while adhering to basic waste utilization standards. Metsera Inc (MTSR) is investing in the creation of unique oral and injectable treatments, backed by powerful research resources. The developers aim to implement a new type of peptides that allow for the correction of metabolism while preserving muscle tissue.

Metsera Corp (MTSR) Ratio of Short-Term Indebtedness to Capital: for the period 02/01/2025 - 11/29/2025

Metric breakdowns and analytics for metsera.com (MTSR)

- price and consensus price forecast:
Stock Price Metsera Corp|MTSR - Fair Value Consensus
- market capitalization data:
Market Capitalization Metsera, Inc.|MTSR - Enterprise Value
- book capitalization data:
Net Assets per Single Share Metsera|MTSR - Accounting Value of Company|Market Value to Book Value Ratio metsera.com|MTSR - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Metsera Inc|MTSR - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Metsera|MTSR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Metsera, Inc.|MTSR - Company Long-Term Liabilities|Company Short-Term Debts Metsera
General company analysis:Metsera Corp MTSR
Brand item of Metsera, Inc.

It is crucial for investors to mitigate the risk of overpaying for an asset by evaluating the proportion of liabilities with maturities exceeding one year relative to the issuer's equity through the current short-term debt-to-equity ratio. For the biotech firm Metsera Inc (MTSR), which burns capital in R&D to secure a future patent monopoly, this metric confirms its ability to fund development without a critical debt load, ensuring the operational stability of the business.

Analysis of competing companies

Ascendis Pharma Inc. (ASND) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Madrigal Corp (MDGL)|Short-Term Debt to Capital CORT (Corcept Therapeutics)|rhythmtx.com - Short-Term Debt to Capital|Short-Term Debt to Equity Akero (AKRO)|MLTX: Ratio of Short-Term Indebtedness to Capital|CRNX (Crinetics Pharma) - Short-Term Debt to Equity|NewAmsterdam Pharma Corp (NAMS) - Short-Term Debt to Equity Ratio|SLNO (Soleno Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital amicusrx.com (FOLD)|89bio (ETNB) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AGIO (Agios)|Structure Pharma - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio MiMedx Corp MDXG|RZLT (Rezolute, Inc.) - Short-Term Debt to Capital|lexpharma.com (LXRX) - Current Liabilities to Capital|MBX - Short-Term Debt to Equity Ratio|Altimmune Inc (ALT) - Short-Term Loans to Capital Ratio|AARD (Aardvark Therapeutics Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Sagimet Biosciences Inc|Short-Term Debt to Capital BioAge Labs, Inc. (BIOA)|Short-Term Debt to Equity BMEA (biomeafusion.com)|QNCX: Short-Term Debt to Equity|Fractyl Health Inc. - Current Liabilities to Capital|VTVT - Short-Term Debt to Equity|ATPC - Short-Term Debt to Equity|pluri-biotech.com - Short-Term Debt to Capital|SYBX (Synlogic) - Short-Term Debt to Capital Coefficient|LPCN: Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient MTNB|Short-Term Debt to Equity SPRB (Spruce Biosciences)|Short-Term Debt to Equity Ratio GLTO (Galecto Corporation)|Carmell Corporation - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio lumos-pharma.com LUMO|ONVO (Organovo) - Short-Term Debt to Capital|Radius Recycling Inc. (RDUS) - Current Liabilities to Capital